Barrick Mining Corporation (ABR0)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 34.90 |
|---|---|
| 52-week range | 26.10 – 45.69 |
| Return, 1 month / 3 months | −6.3% / +7.8% |
| Return, 1 year / 3 years | +30.7% / +146.1% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 44.2% |
| Worst drawdown (1 year) | -30.0% |
| Average daily value traded | 1.20M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Barrick Mining Corporation is a gold and copper producer based in Canada. It operates mines across the Americas, Africa and the Asia-Pacific region, extracting gold and copper ores and processing them into doré bars and concentrate for sale to refiners and smelters. The company also explores for and develops mineral deposits, and its operations supply precious and base metals to industrial and jewellery markets around the world.
The shares are listed on the Deutsche Börse Xetra in Germany under the code ABR0, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Barrick Mining Corporation (ABR0) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 34.90 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 270 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.7% and over the last three months it rose 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.6% | ||
| From 52-week high | -20.8% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.8% | ||
| 6-month return | 2.3% | ||
| 12-month return, skipping the last month | 39.5% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.0% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 1.20M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −6.3% |
| 3 months | +7.8% |
| 6 months | +2.3% |
| 1 year | +30.7% |
| 3 years | +146.1% |
| 5 years | +134.2% |
Signals
| 50-day / 200-day average | 37.21 / 36.20 |
|---|---|
| Golden / death cross (60 days) | Golden, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Aug 2026 | CAD 0.1557 |
| 29 May 2026 | CAD 0.1557 |
| 27 Feb 2026 | CAD 0.3736 |
| 28 Nov 2025 | CAD 0.1557 |
| 29 Aug 2025 | CAD 0.1334 |
| 30 May 2025 | CAD 0.0890 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.